--- title: "RWE for Reimbursement, Definition | MedTech Terms" description: "Real-world evidence used to support coverage and payment decisions. Plain-English Reimbursement definition for MedTech teams, with examples and related terms." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/real-world-evidence-reimbursement#term", "name": "RWE for Reimbursement", "description": "Real-world evidence - from registries, claims data, and EHRs - increasingly supports CMS coverage decisions, NICE technology appraisals, and EU JCA dossiers, particularly for technologies where RCTs are infeasible or have completed.", "url": "https://medtechterms.com/terms/real-world-evidence-reimbursement", "termCode": "real-world-evidence-reimbursement", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/real-world-evidence-reimbursement#article", "headline": "RWE for Reimbursement", "description": "Real-world evidence used to support coverage and payment decisions.", "url": "https://medtechterms.com/terms/real-world-evidence-reimbursement", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/real-world-evidence-reimbursement" }, "about": { "@id": "https://medtechterms.com/terms/real-world-evidence-reimbursement#term" }, "articleSection": "Reimbursement", "inLanguage": "en", "keywords": "RWE for Reimbursement, Reimbursement, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "AMA CPT Resources", "url": "https://www.ama-assn.org/practice-management/cpt", "publisher": { "@type": "Organization", "name": "AMA" } }, { "@type": "CreativeWork", "name": "AdvaMed - Payment & Coverage", "url": "https://www.advamed.org/our-work/", "publisher": { "@type": "Organization", "name": "AdvaMed" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/lcd-ncd#term", "name": "LCD and NCD", "url": "https://medtechterms.com/terms/lcd-ncd" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/ced#term", "name": "Coverage with Evidence Development", "alternateName": "CED", "url": "https://medtechterms.com/terms/ced" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/real-world-evidence#term", "name": "Real-World Evidence", "alternateName": "RWE", "url": "https://medtechterms.com/terms/real-world-evidence" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Reimbursement", "item": "https://medtechterms.com/terms?cat=Reimbursement" }, { "@type": "ListItem", "position": 4, "name": "RWE for Reimbursement", "item": "https://medtechterms.com/terms/real-world-evidence-reimbursement" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/real-world-evidence-reimbursement#faq", "mainEntity": [ { "@type": "Question", "name": "What types of data constitute Real-World Evidence for reimbursement?", "acceptedAnswer": { "@type": "Answer", "text": "Real-world evidence for reimbursement typically includes data from patient registries, electronic health records (EHRs), claims databases, and observational studies. These data sources provide insights into how devices perform in routine clinical practice." } }, { "@type": "Question", "name": "How does the FDA view Real-World Evidence for regulatory submissions versus reimbursement?", "acceptedAnswer": { "@type": "Answer", "text": "The FDA primarily focuses on RWE for regulatory decisions, such as approvals or label expansions, assessing safety and effectiveness. While the FDA's acceptance of RWE can influence reimbursement, HTA bodies and payers focus specifically on cost-effectiveness and comparative effectiveness for coverage decisions." } }, { "@type": "Question", "name": "Is RWE always accepted for reimbursement in the same way as RCT data?", "acceptedAnswer": { "@type": "Answer", "text": "No, RWE is not always accepted in the same way as data from randomized controlled trials. While increasingly valued, its acceptance depends on the regulatory body, the quality of the data, the specific clinical question, and the availability of clear methodologies for its use, as highlighted by various HTA guidelines." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Reimbursement](/terms?cat=Reimbursement) 6. / 7. RWE for Reimbursement [All terms](/terms) Reimbursement [Clinical Evidence](/ecosystems/clinical-evidence)[Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) # RWE for Reimbursement Real-world evidence used to support coverage and payment decisions. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition [Real-world evidence](/terms/real-world-evidence) - from registries, claims data, and EHRs - increasingly supports CMS coverage decisions, NICE technology appraisals, and EU [JCA](/terms/jca) dossiers, particularly for technologies where RCTs are infeasible or have completed. What the regulation says [Real-world evidence](/terms/real-world-evidence) (RWE) is utilized by regulatory bodies and [health technology assessment](/terms/hta) (HTA) agencies, such as the Centers for Medicare & Medicaid Services (CMS) in the US and the National Institute for Health and Care Excellence (NICE) in the UK, to inform coverage and reimbursement decisions, especially when randomized controlled trials (RCTs) are impractical or have been completed. The EU [Joint Clinical Assessment](/terms/jca) (JCA) also considers RWE dossiers. The FDA provides guidance on the use of RWE, for example, in "Real-World Evidence Program, Guidance for Industry" (2023). ## What this means in practice Registry-based evidence (TVT, NCDR, ACC/STS) underpins coverage for [structural heart](/terms/structural-heart) and EP devices. Manufacturers must invest in registry strategy alongside trial strategy. ## Examples - A medical device manufacturer uses data from a post-market registry to demonstrate the long-term effectiveness and safety of a novel cardiac implant, leading CMS to expand its coverage policy. - A company submits an RWE dossier, including claims data and EHR extracts, to NICE to support a positive technology appraisal for a connected health solution for diabetes management. - After an initial randomized controlled trial, a MedTech firm collects RWE on a surgical robot through a dedicated real-world study, which is then used to negotiate favorable reimbursement rates with private payers. Common pitfalls - • Assuming RWE always replaces the need for premarket clinical trials, rather than complementing them, is a common error. - • Failing to establish robust data quality and governance for RWE collection can lead to rejections from reimbursement bodies. - • Ignoring the specific evidence requirements of different reimbursement authorities for RWE submissions can result in delays or denials. - • Underestimating the resources and expertise required to collect, analyze, and present RWE effectively is a frequent pitfall. ## Frequently asked questions What types of data constitute Real-World Evidence for reimbursement? [Real-world evidence](/terms/real-world-evidence) for reimbursement typically includes data from patient registries, electronic health records (EHRs), claims databases, and observational studies. These data sources provide insights into how devices perform in routine clinical practice. How does the FDA view Real-World Evidence for regulatory submissions versus reimbursement? Is RWE always accepted for reimbursement in the same way as RCT data? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Reimbursement LCD and NCD Local and National Coverage Determinations from Medicare. ](/terms/lcd-ncd)[ Reimbursement Coverage with Evidence Development(CED) Medicare paradigm conditioning coverage on participation in approved clinical studies or registries. ](/terms/ced)[ Clinical & Trials Real-World Evidence(RWE) Clinical evidence regarding the usage and potential benefits or risks of a device derived from real-world data. ](/terms/real-world-evidence) ### Reimbursement & Market Access · From this learning path [ Reimbursement Value-Based Care(VBC) Payment tied to outcomes and total cost of care, not volume of services. Adjacent lesson ](/terms/value-based-care?from=reimbursement-and-market-access)[ Reimbursement Budget Impact Model(BIM) Financial model that estimates the total cost consequences of adopting a new technology to a payer's budget over a defined horizon. ](/terms/budget-impact-model?from=reimbursement-and-market-access)[ Reimbursement CPT Codes(CPT) AMA-maintained codes that describe medical procedures and services. ](/terms/cpt-codes?from=reimbursement-and-market-access)[ Reimbursement Current Procedural Terminology Codes(CPT) AMA-maintained codes used to report medical procedures and services for billing. ](/terms/cpt?from=reimbursement-and-market-access) ### More in Reimbursement · Same category [ Reimbursement HCPCS Codes(HCPCS) CMS-maintained codes for products, supplies, and services not in CPT. ](/terms/hcpcs) Cited by Where this term appears across MedTech Terms. Learning paths (1) - [Reimbursement & Market Access](/paths/reimbursement-and-market-access)Lesson 14 of 14 Ecosystems (2) - [Clinical Evidence](/ecosystems/clinical-evidence) - [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) ## Primary references 2 sources Link health: 2 verified · last checked 2026-06-20 AMA· 1 AdvaMed· 1 1. [1 AMA CPT Resources Verified AMA · ama-assn.org ](https://www.ama-assn.org/practice-management/cpt) 2. [2 AdvaMed - Payment & Coverage Verified AdvaMed · advamed.org ](https://www.advamed.org/our-work/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Need cybersecurity expertise on a connected-device launch? Blue Goat Cyber helps MedTech teams ship connected products that hospital security teams will actually procure. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Reimbursement Sources 2 Updated 5/5/2026 [Compare with another term](/compare?a=real-world-evidence-reimbursement) Learn in 60 seconds Card Lesson Quiz Real-world evidence used to support coverage and payment decisions. - · Registry-based evidence (TVT, NCDR, ACC/STS) underpins coverage for structural heart and EP devices. - · Manufacturers must invest in registry strategy alongside trial strategy. Remember this Watch out: Assuming RWE always replaces the need for premarket clinical trials, rather than complementing them, is a common error. Related terms - [LCD and NCD ](/terms/lcd-ncd) - [Coverage with Evidence Development(CED) ](/terms/ced) - [Real-World Evidence(RWE) ](/terms/real-world-evidence) You may also need Auto-suggested from Reimbursement and shared keywords. - [Health Economics and Outcomes Research(HEOR) ](/terms/heor) - [Real-World Data(RWD) ](/terms/rwd) - [Health Technology Assessment(HTA) ](/terms/hta) - [Transitional Coverage for Emerging Technologies(TCET) ](/terms/tcet) - [New Technology Add-On Payment(NTAP) ](/terms/ntap) - [Transitional Pass-Through Payment(TPT) ](/terms/tpt) [All Reimbursement terms](/terms?cat=Reimbursement) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)